Evotec SE
XETRA:EVT
Evotec SE
Research & Development
Evotec SE
Research & Development Peer Comparison
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
E
|
Evotec SE
XETRA:EVT
|
Research & Development
-€68.5m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-22%
|
Gerresheimer AG
XETRA:GXI
|
Research & Development
-€13m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
S
|
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
|
Research & Development
-€26.8m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Evotec SE's Research & Development?
Research & Development
-68.5m
EUR
Based on the financial report for Dec 31, 2023, Evotec SE's Research & Development amounts to -68.5m EUR.
What is Evotec SE's Research & Development growth rate?
Research & Development CAGR 10Y
-22%
Over the last year, the Research & Development growth was 11%. The average annual Research & Development growth rates for Evotec SE have been -2% over the past three years , -14% over the past five years , and -22% over the past ten years .